Investor Relations

In October 2015, the Company’s Board of Directors authorized the Company to cease reporting under the Securites Exchange Act of 1934, as amended. As a result of this action, the Company’s common stock has ceased trading on the OTCQB but will continue to be quoted in the OTC Pink Marketplace under the symbol HKNI.

Please be advised that applicable federal securities laws and regulations preclude HKN from disclosing to individual investors material information regarding HKN and its securities that is not disseminated publicly to all HKN stockholders. Accordingly, HKN will not respond to any investor inquiries that seek undisclosed material information or engage in discussions with individual investors regarding such information.

The materials contained in this web site include forward-looking statements as defined by federal law and regulations including, without limitation, those enacted by the Securities and Exchange Commission. The forward-looking statements contained throughout this web site reflect the current view of management with regard to its forecasts and other future events. Management’s current view and plans, however, are subject to numerous known and unknown risks, uncertainties and other factors that may cause the actual results, performance, timing or achievements of HKN to be materially different from any results, performance, timing or achievements expressed or implied by such forward-looking statements. These risks, uncertainties and other factors include, among others, the risks described in HKN’s Annual Report filed with the OTC Marketplace. HKN encourages you to review the description of the risks contained in its filings. Although HKN believes that the expectations reflected in these forward-looking statements are reasonable, it can give no assurance that such expectations will prove to be correct or that unforeseen developments will not occur. HKN undertakes no duty to update or revise any forward-looking statements.

You can contact HKN, Inc. Investor Relations by calling 212.231.3906 or by email at [email protected].